Establishing the operating conditions of Ocula AI in capturing the pupil light reflex

Abstract

In recent years, rapid advances in technology have made it possible to monitor human health with personal handheld devices. While initially limited to measures of electrical skin potential for cardiac assessment, this has now expanded to include brain health by leveraging visual reflexes. In this study, we examine the effectiveness of a cutting-edge smartphone application, Ocula AI (Equinox), to capture and quantify the pupillary light reflex (PLR). In particular, the present study evaluates and compares the capability and operating range of Ocula AI, against an established clinical-standard device, the PLR-3000 pupillometer (NeurOptics). Both devices captures the PLR waveform providing estimates of key metrics such as such as latency, maximum and minimum pupils, and constriction and dilation velocities. The ability of Ocula AI to capture the PLR was assessed under different indoor illumination conditions (indicated by illuminance levels ranging from 0 to 1200 lux) in 16 healthy young adults. Our comparison and Bland-Altman analyses showed that Ocula AI effectively and reliably captured the PLR and estimated key features of the PLR waveform to a similar standard and with high agreement to the PLR-3000 device. Furthermore, Ocula AI was capable of capturing the PLR up to approximately 1000 lux, at which point the pupils are maximally constricted. These results provided preliminary evidence of the utility and potential benefit of mobile devices in providing accurate and easy estimation of the PLR.

Competing Interest Statement

The research was funded by Equinox Ventures to establish the capabilities of the Ocula AI app. No input was provided in the design of the study conducted. BO was a technical consultant for the study and is an employee of Equinox Ventures

Funding Statement

This study was funded by Equinox Ventures

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The University of New South Wales Human Ethics Committee (HREA Biomedical) Ethics number:

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Comments (0)

No login
gif